hu14.18-Interleukin-2 fusion protein

hu14.18-IL-2

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for hu14.18-Interleukin-2 fusion protein, covering 2014-01-16 to 2019-11-19. Get the full timeline:

Most recent: Clinical Trial Update: Hu14.18-Interleukin-2 Fusion Protein in Treating Patients With Advanced Melanoma [Phase 2]